Vertex Pharmaceuticals, Inc. (VRTX)

515.44 +0.88 (+0.17%) USD  |  NASDAQ  |  Sep 11, 16:00
514.10 -1.34 (-0.26%) Pre-Market: 09:22
More

Vertex Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Quarterly Actual Revenue Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
Date Value
June 30, 2025 --
March 31, 2025 --
December 31, 2024 --
September 30, 2024 --

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Sionna Therapeutics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Biogen, Inc. Upgrade